Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Neoplasms, Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01553578
What this trial is testing

Healing Touch or Guided Imagery In Treating Pain, Fatigue, Nausea, and Anxiety in Patients Undergoing Chemotherapy

Who this might be right for
Anxiety DisorderFatigueMalignant Neoplasm+2 more
Wake Forest University Health Sciences 244
Early research (Phase 1)Study completedNCT02640755
What this trial is testing

Absorption, Metabolism, Excretion and Pharmacokinetics of a Single Dose [14C]AZD2014 Followed by a Multiple Dose Phase

Who this might be right for
Solid Malignancies
AstraZeneca 4
Not applicableStudy completedNCT00042926
What this trial is testing

Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer

Who this might be right for
Head and Neck Cancer
Alliance for Clinical Trials in Oncology 161
Testing effectiveness (Phase 2)Study completedNCT00244985
What this trial is testing

Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Roswell Park Cancer Institute 42
Early research (Phase 1)Not Yet RecruitingNCT07720843
What this trial is testing

TAlquetamab and BeLantamab Mafodotin in Relapsed/Refractory Multiple Myeloma (TaBleMM)

Who this might be right for
Relapse Multiple MyelomaRefractory Multiple Myeloma
Montefiore Medical Center 50
Testing effectiveness (Phase 2)Study completedNCT00026143
What this trial is testing

Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 60
Post-approval studies (Phase 4)UnknownNCT06055543
What this trial is testing

Impact of a New Plant-based High-energy Oral Nutritional Supplement on Nutritional Outcomes in Malnourished Patients

Who this might be right for
MalnutritionCancerInflammatory Bowel Diseases+2 more
Danone Specialized Nutrition 140
Not applicableStudy completedNCT02353715
What this trial is testing

Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise Testing

Who this might be right for
Prostate Cancer
Duke University 38
Testing effectiveness (Phase 2)UnknownNCT05602415
What this trial is testing

Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma

Who this might be right for
Soft Tissue SarcomaHigh Risk of RecurrenceAnlotinib+1 more
Ruijin Hospital 41
Early research (Phase 1)Ended earlyNCT01790035
What this trial is testing

Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer

Who this might be right for
Gastrointestinal Neoplasms
Washington University School of Medicine 23
Testing effectiveness (Phase 2)Study completedNCT00720876
What this trial is testing

Vorinostat and Rituximab in Treating Patients With Indolent Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
City of Hope Medical Center 30
Post-approval studies (Phase 4)Study completedNCT00230217
What this trial is testing

Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy

Who this might be right for
TumorsHyperuricemiaTumor Lysis Syndrome
Sanofi 94
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07169617
What this trial is testing

Testing the SurVaxM Vaccine for Lung Cancer Prevention

Who this might be right for
Lung Carcinoma
National Cancer Institute (NCI) 80
Large-scale testing (Phase 3)UnknownNCT03415763
What this trial is testing

Adjuvant Chemotherapy in Patients With Clinical Stage III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy

Who this might be right for
Rectal Neoplasms
LI XIN-XIANG 764
Early research (Phase 1)Study completedNCT03730363
What this trial is testing

Pentamidine + Salvage Chemo for Relapsed/Refractory Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaRefractory Hodgkin Lymphoma
Reinhold Munker 1
Not applicableStudy completedNCT04872621
What this trial is testing

Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient Investigation

Who this might be right for
Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
AstraZeneca 104
Testing effectiveness (Phase 2)Temporarily pausedNCT03417921
What this trial is testing

ABTL0812 in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Ability Pharmaceuticals SL 60
Not applicableActive Not RecruitingNCT03364621
What this trial is testing

Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy

Who this might be right for
Colorectal CancerColorectal Cancer MetastaticHepatic Metastases
University Health Network, Toronto 17
Not applicableLooking for participantsNCT06501521
What this trial is testing

Non-invasive Brain Tumor Molecular Diagnostics and Monitoring

Who this might be right for
Brain Tumor
The Institute of Molecular and Translational Medicine, Czech Republic 200
Testing effectiveness (Phase 2)Study completedNCT01519414
What this trial is testing

Tivantinib in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerProstate AdenocarcinomaRecurrent Prostate Carcinoma+1 more
National Cancer Institute (NCI) 78
Next Page